Estabrook Capital Management’s Moderna MRNA Stock Holding History

Estabrook Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$66.8K	–	353
2024 Q3	$66.8K	Hold	1,000	–	–	0.01%	182
2024 Q2	$119K	Hold	1,000	–	–	0.02%	153
2024 Q1	$107K	Hold	1,000	–	–	0.02%	158
2023 Q4	$99.5K	Hold	1,000	–	–	0.02%	161
2023 Q3	$103K	Hold	1,000	–	–	0.02%	158
2023 Q2	$122K	Hold	1,000	–	–	0.02%	153
2023 Q1	$154K	Hold	1,000	–	–	0.03%	144
2022 Q4	$180K	Hold	1,000	–	–	0.03%	139
2022 Q3	$118K	Hold	1,000	–	–	0.02%	154
2022 Q2	$143K	Hold	1,000	–	–	0.02%	150
2022 Q1	$172K	Sell	1,000 -250	-20%	-$42.1K	0.03%	145
2021 Q4	$317K	Buy	+1,250	New	+$365K	0.05%	124

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Estabrook Capital Management's MRNA Position: Q4 2024 in Review

Estabrook Capital Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 1,000 shares — an estimated $66.8K sold.

Estabrook Capital Management first reported a position in MRNA in Q4 2021 and held it in 12 quarters. The position peaked at $317K in Q4 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

Estabrook Capital Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
Estabrook Capital Management sold 1,000 Moderna shares in Q4 2024, an estimated $66.8K.
Estabrook Capital Management first reported a position in Moderna in Q4 2021 and held it in 12 quarters.
Estabrook Capital Management's Moderna position peaked at $317K in Q4 2021.
745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Estabrook Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.